![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Chemomab Therapeutics Ltd | NASDAQ:CMMB | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.135 | 10.93% | 1.37 | 1.35 | 1.43 | 1.58 | 1.22 | 1.22 | 409,453 | 22:24:55 |
Chemomab Therapeutics Ltd.
|
(Name of Issuer)
|
|
Ordinary Shares, no par value per share
|
(Title of Class of Securities)
|
|
16385C104**
|
(CUSIP Number)
|
March 16, 2021
|
(Date of Event which Requires Filing of this Statement)
|
CUSIP No. 16385C104
|
||||
1
|
NAMES OF REPORTING PERSONS
|
|||
Rivendell Investments 2017-9 LLC
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|||
(a) ☐
(b) ☐ |
||||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|||
Delaware
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY
EACH REPORTING PERSON WITH: |
5
|
SOLE VOTING POWER
|
||
22,631,260 Ordinary Shares(1)
|
||||
6
|
SHARED VOTING POWER
|
|||
0
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|||
22,631,260 Ordinary Shares(1)
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|||
0
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
22,631,260 Ordinary Shares(1)
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|||
☐
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|||
10.6%(2)
|
||||
12
|
TYPE OF REPORTING PERSON
|
|||
OO
|
CUSIP No. 16385C104
|
||||
1
|
NAMES OF REPORTING PERSONS
|
|||
Peter Thiel
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|||
(a) ☐
(b) ☐ |
||||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|||
United States
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY
EACH REPORTING PERSON WITH: |
5
|
SOLE VOTING POWER
|
||
22,631,260 Ordinary Shares(1)(2)
|
||||
6
|
SHARED VOTING POWER
|
|||
0
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|||
22,631,260 Ordinary Shares(1)(2)
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|||
0
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
22,631,260 Ordinary Shares(1)(2)
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|||
☐
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|||
10.6%(3)
|
||||
12
|
TYPE OF REPORTING PERSON
|
|||
IN
|
1.
|
Rivendell Investments 2017-9 LLC
|
2.
|
Peter Thiel
|
(a)
|
Amount beneficially owned:
|
|||
See Row 9 of cover page for each Reporting Person.
|
||||
(b)
|
Percent of class:
|
|||
See Row 11 of cover page for each Reporting Person.
|
||||
(c)
|
Number of shares as to which the person has:
|
|||
(i)
|
Sole power to vote or to direct the vote:
|
|||
See Row 5 of cover page for each Reporting Person.
|
||||
(ii)
|
Shared power to vote or to direct the vote:
|
|||
See Row 6 of cover page for each Reporting Person.
|
||||
(iii) | Sole power to dispose or to direct the disposition of: |
See Row 7 of cover page for each Reporting Person.
|
||||
(iv)
|
Shared power to dispose or to direct the disposition of:
|
|||
See Row 8 of cover page for each Reporting Person.
|
Dated: March 26, 2021
|
RIVENDELL INVESTMENTS 2017-9 LLC
|
By: /s/ Peter Thiel
|
|
Name: Peter Thiel
|
|
Title: Authorized Signatory
|
|
/s/ Peter Thiel
|
|
Peter Thiel
|
|
Dated: March 26, 2021
|
RIVENDELL INVESTMENTS 2017-9 LLC
|
By: /s/ Peter Thiel
|
|
Name: Peter Thiel
|
|
Title: Authorized Signatory
|
|
/s/ Peter Thiel
|
|
Peter Thiel
|
|
1 Year Chemomab Therapeutics Chart |
1 Month Chemomab Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions